ACVBP-R regimen

Jump to navigation Jump to search

WikiDoc Resources for ACVBP-R regimen

Articles

Most recent articles on ACVBP-R regimen

Most cited articles on ACVBP-R regimen

Review articles on ACVBP-R regimen

Articles on ACVBP-R regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on ACVBP-R regimen

Images of ACVBP-R regimen

Photos of ACVBP-R regimen

Podcasts & MP3s on ACVBP-R regimen

Videos on ACVBP-R regimen

Evidence Based Medicine

Cochrane Collaboration on ACVBP-R regimen

Bandolier on ACVBP-R regimen

TRIP on ACVBP-R regimen

Clinical Trials

Ongoing Trials on ACVBP-R regimen at Clinical Trials.gov

Trial results on ACVBP-R regimen

Clinical Trials on ACVBP-R regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on ACVBP-R regimen

NICE Guidance on ACVBP-R regimen

NHS PRODIGY Guidance

FDA on ACVBP-R regimen

CDC on ACVBP-R regimen

Books

Books on ACVBP-R regimen

News

ACVBP-R regimen in the news

Be alerted to news on ACVBP-R regimen

News trends on ACVBP-R regimen

Commentary

Blogs on ACVBP-R regimen

Definitions

Definitions of ACVBP-R regimen

Patient Resources / Community

Patient resources on ACVBP-R regimen

Discussion groups on ACVBP-R regimen

Patient Handouts on ACVBP-R regimen

Directions to Hospitals Treating ACVBP-R regimen

Risk calculators and risk factors for ACVBP-R regimen

Healthcare Provider Resources

Symptoms of ACVBP-R regimen

Causes & Risk Factors for ACVBP-R regimen

Diagnostic studies for ACVBP-R regimen

Treatment of ACVBP-R regimen

Continuing Medical Education (CME)

CME Programs on ACVBP-R regimen

International

ACVBP-R regimen en Espanol

ACVBP-R regimen en Francais

Business

ACVBP-R regimen in the Marketplace

Patents on ACVBP-R regimen

Experimental / Informatics

List of terms related to ACVBP-R regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Adriamycin-Cytoxan-Vindesine-Bleomycin-Prednisone-Rituximab Regimen

Overview

ACVBP-R regimen refers to a chemotherapy regimen consisting of doxorubicin, cyclophosphamide, vindesine, bleomycin, prednisone, and rituximab used in the treatment of non-Hodgkin lymphoma.

Regimen

ADoxorubicin (Adriamycin)

CCyclophosphamide

VVindesine

BBleomycin

PPrednisone

RRituximab

Indications

References

  1. Récher C, Coiffier B, Haioun C, Molina TJ, Fermé C, Casasnovas O; et al. (2011). "Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial". Lancet. 378 (9806): 1858–67. doi:10.1016/S0140-6736(11)61040-4. PMID 22118442.